{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:53:13Z","timestamp":1759179193225},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ijantimicag.2003.07.005","type":"journal-article","created":{"date-parts":[[2004,1,17]],"date-time":"2004-01-17T10:15:06Z","timestamp":1074334506000},"page":"204-207","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection"],"prefix":"10.1016","volume":"23","author":[{"given":"Bilgin","family":"Arda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fcr\u015fide","family":"Tun\u00e7el","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tansu","family":"Yaimazhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"G\u00f6kengin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB1","unstructured":"Report of the Turkish Ministry of Health, Division of Communicable Diseases, May 2001."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinids\/21.2.283","article-title":"An overview of human brucellosis","volume":"21","author":"Young","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB3","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.37.9.1831","article-title":"Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin","volume":"37","author":"Akova","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB4","first-page":"5","article-title":"Problems of therapy in brucellosis","volume":"6","author":"Ural","year":"2001","journal-title":"Flora"},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.37.11.2333","article-title":"Therapy of experimental murine brucellosis with streptomycin alone and combination with ciprofloxacin, doxycyline and rifampin","volume":"37","author":"Lang","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB6","first-page":"481","article-title":"Rifampicin in the treatment of experimental brucellosis in mice and guinea pigs","volume":"136","author":"Phillipon","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/AAC.43.1.194","article-title":"In vitro activities of six new fluoroquinolones against Brucella melitensis","volume":"43","author":"Martin","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/AAC.35.6.1116","article-title":"Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin","volume":"35","author":"Fred","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0147-9571(01)00009-1","article-title":"Therapeutic effect of anti-TNF alpha antibody and levofloxacin in a mouse model of enterohemorrhagic Escherichia coli O157 infection","author":"Isogai","year":"2001","journal-title":"Comp. Immun. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/313677","article-title":"New uses for new and old quinolones and the challenge of resistance","volume":"30","author":"Hooper","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/AAC.37.4.911","article-title":"In vitro activities of new macrolides and rifapentine against Brucella spp.","volume":"37","author":"Gardia Rodriguez","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB12","first-page":"599","article-title":"Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy","volume":"48","author":"Brogen","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/infdis\/136.4.482","article-title":"Rifampicin in the treatment of experimental brucellosis in mice and guinea pigs","volume":"136","author":"Philippon","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1128\/AAC.36.5.973","article-title":"Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline and rifampin","volume":"36","author":"Shasha","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.005_BIB15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jac\/33.3.545","article-title":"Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis","volume":"33","author":"Shasha","year":"1994","journal-title":"J. Antimicrob. Chemother."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903003790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T04:12:16Z","timestamp":1585455136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903003790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0924857903003790"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.07.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}